Kanname hoolt inimeste tervise eest igas maailma nurgas
Choose a category or subcategory
B. Braun Grupi uudised
Personalized cancer therapy: B. Braun and CeGaT found joint venture CeCaVa
Melsungen/Tübingen – The medical technology and pharmaceutical manufacturer B. Braun Melsungen AG and CeGaT GmbH in Tübingen have announced the creation of the joint venture CeCaVa GmbH & Co. KG.
Anna Maria Braun to succeed Heinz-Walter Große as Chairman of the Management Board of B. Braun Melsungen AG in April 2019
The Supervisory Board of B. Braun Melsungen AG decided in its meeting of today that Anna Maria Braun (39) will assume the Chairmanship of the Management Board of B. Braun Melsungen AG effective April 1st, 2019.
Personnel Changes in Supervisory and Management Board of Aesculap AG
With a meeting on July 10, Professor Ludwig Georg Braun ended his mandate as chairman of the Supervisory Board of Aesculap AG. After more than 42 years of being a member, Professor Braun decided not to stand for re-election. With immediate efficiency, Prof. Dr. Heinz Walter Grosse, Chairman of the Management Board of B. Braun Melsungen AG, was unanimously elected to his position.